Cargando…
Activators and inhibitors of the plasminogen system in Alzheimer’s disease
Accumulation and deposition of Aβ is one of the main neuropathological hallmarks of Alzheimer’s disease (AD) and impaired Aβ degradation may be one mechanism of accumulation. Plasmin is the key protease of the plasminogen system and can cleave Aβ. Plasmin is activated from plasminogen by tissue plas...
Autores principales: | Barker, Rachel, Kehoe, Patrick G, Love, Seth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822855/ https://www.ncbi.nlm.nih.gov/pubmed/21790972 http://dx.doi.org/10.1111/j.1582-4934.2011.01394.x |
Ejemplares similares
-
The plasminogen activating system in the pathogenesis of Alzheimer’s disease
por: Yepes, Manuel
Publicado: (2021) -
Pathophysiology of white matter perfusion in Alzheimer’s disease and vascular dementia
por: Barker, Rachel, et al.
Publicado: (2014) -
Aging, Plasminogen Activator Inhibitor 1, Brain Cell Senescence, and Alzheimer’s Disease
por: Jiang, Chun-Sun, et al.
Publicado: (2023) -
Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995) -
Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in Patients with Acute Paraquat Intoxication
por: Seok, Su-Jin, et al.
Publicado: (2011)